About
Artificial pancreas device
Areas of Focus
Categories
Drug Delivery Device
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
533
By Phase
NA: 4
By Status
COMPLETED: 3UNKNOWN: 1RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05733962Lead Sponsor
Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes
NAUnknown
40 participants
Started: Jan 31, 2024 · Completed: Jan 31, 2025
NCT05628532Lead Sponsor
DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial
NACompleted
90 participants
Started: Feb 3, 2023 · Completed: Apr 29, 2024
NCT05369871Lead Sponsor
Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)
NACompleted
20 participants
Started: Aug 29, 2022 · Completed: Jul 28, 2023
NCT04749693Lead Sponsor
Observational Study of the Use of DBLG1 System in Real Life
N/ARecruiting
348 participants
Started: May 17, 2021 · Completed: Jan 31, 2026
NCT04522882Lead Sponsor
Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1
NACompleted
35 participants
Started: Sep 9, 2020 · Completed: Dec 31, 2020
Locations (1)
Headquarters
Grenoble, France
Map
Loading map...